Abstract
As preoperative adjuvant therapy for advanced lung cancer, bronchial arterial infusion (BAI) of a chemotherapeutic agent was administered to patients with stage IIIa and IIIb hilar lung cancer. The infusion modality was changed for each term, from a single drug infusion, to a two drug infusion and then a three drug infusion, and the combination of infused drugs was selected in accordance with cell types. A significant radiographic shrinkage was observed after BAI therapy by the single, two and three drug infusions, being noted as 40.7 per cent, 61.8 per cent and 83.9 per cent, respectively. The effect on squamous cell carcinoma was more prominent than on other cell types. Upon microscopic examination of the resected specimens, significant histo-pathological effects were observed in 57.7 per cent of the patients who received single or two drug infusions, while the rate increased to as high as 92.2 per cent in the patients who received the three drug infusion. The histological effects of BAI therapy were also most marked in squamous cell carcinoma. It is of special interest that 5 of the 10 patients who received the three drug infusion of Carboquone (CQ)+ Mitomycin C (MMC)+Nimustine-HCL (ACNU) for squamous cell carcinoma, showed complete disappearance of viable cancer cells at the tumor site; something which was never observed after the single and two drug infusions. It was therefore concluded that BAI therapy for advanced lung cancer should be reappraised through the modification of infusion methods.
Similar content being viewed by others
References
Watanabe Y, Yamada T, Ichihashi T, Hashizume Y, Iwa T. Surgical adjuvant therapy for non-small cell lung cancer. Gan to Kagakuryoho (Jap J Cancer Chemother) 1986; 13 (part II): 1534–1546. (English Abst.)
Komori Y, Yamada T, Funaki Y, Watanabe Y, Iwa T. Effect of intra-arterial chemotherapy in lung cancer. Gan no Rinsho (Jap J Cancer Clin) 1978; 24: 1191–1196. (English Abst.)
Collaborative study. Preoperative irradiation of cancer of the lung. Cancer 1975; 36: 914–925.
Shields TW, Higgins GA, Lawton R, Lawton R, Heilbrunn A, Keehn RJ. Preoperative X-ray therapy as an adjuvant in the treatment of bronchogenic carcinoma. J Thorac Cardiovas Surg 1970; 59: 49–61.
Viamonte M Jr. Selective bronchial arteriography in man. Preliminary report. Radiology 1964; 83: 830–839.
Watanabe Y, Nagai A, Oohashi Y, Yoshida C, Kuroda Y, Bando T. Selective bronchial arteriograaphy for the study of the effect of radiation therapy on tumor vessels of bronchogenic carcinoma. Nihon Kyobu Rinsho (Jap J Chest Clin) 1973; 27: 671–681. (English Abst.)
Watanabe Y, Iwa T, Fukatani G, Kuroda Y, Oohashi Y, Yoshida C, Kihara K, Mori A, Sato H, Komori Y. Clinical evaluation of bronchial arteriography for lung disease. Nihon Kyobu Rinsho (Jap J Chest Clin) 1976; 35: 917–922. (English Abst.)
Haller JD, Bron KM, Wholey MH, Poller S, Enerson DM. Selective bronchial artery catheterization for diagnostic and physiologic studies and chemotherapy for bronchogenic carcinoma. J Thorac Cardiovasc Surg 1966; 51: 143–152.
Kahn PC, Paul RE, Rheinlander HF. Selective bronchial arteriography and intra-arterial chemotherapy in carcinoma of the lung. J Thorac Cardiovasc Surg 1965; 50: 640–647.
Tate CF Jr, Viamonte M Jr, Agnew JR. Bronchial arterial perfusion with cytotoxic agents for bronchogenic carcinoma. Preliminary report. Amer Rev Resp Dis 1968; 97: 685–693.
Neyazaki T, Ikeda M, Seki Y, Egawa N, Suzuki C. Bronchial artery infusion therapy for lung cancer. Cancer 1969; 24: 912–922.
Watanabe Y, Kuroda Y, Sato H, Iwa T. Clinical evaluation of Carboquone for treatment of lung cancer with special reference to its effect by bronchial arterial infusion. Gan to Kagakuryoho (Jap J Cancer Chemother) 1976; 3: 85–91. (English Abst.)
Neyazaki T, Hashimoto K, Nakada T, Suzuki C. Long-term results of preoperative bronchial arterial infusion therapy for lung cancer. Kyobu Geka (Jap J Thorac Surg) 1975; 28: 838–843. (English Abst.)
Ogawa S, Ishihara T, Kikuchi K, Inoue K, Fukai S, Takanami I, Busi A, Ikeda T. Bronchial arterial infusion therapy for inoperable bronchogenic carcinoma. Kyobu Geka (Jap J Thorac Surg) 1977; 30: 640–645. (English Abst.)
Watanabe Y, Iwa T. Clinical value of immunohherapy by streptococcal preparation, OK-432, as an adjuvant for lung cancer. Cancer 1984; 53: 248–253.
Watanabe Y, Iwa T. Immunotherapy of lung cancer: A randomized clinical trial of OK-432 immunotherapy and a review of the literature on nonspecific immunotherapy. Internat J Immunother 1986; 2: 51–67.
Watanabe Y, Iwa T. Clinical value of immunotherapy with the streptococcal preparation OK-432 in non-small cell lung cancer. J Biol Response Modif 1987; 6: 169–180.
Einhorn LH. Neoadjuvant therapy of stage III non-small cell lung cancer. Ann Thorac Surg 1988; 46: 362–365.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Watanabe, Y., Shimizu, J., Murakami, S. et al. Reappraisal of bronchial arterial infusion therapy for advanced lung cancer. The Japanese Journal of Surgery 20, 27–35 (1990). https://doi.org/10.1007/BF02470710
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02470710